Hospira, Inc. (NYSE:HSP)

CAPS Rating: 2 out of 5

A specialty pharmaceutical and medication delivery company that is focused on products that improve the productivity, safety and efficacy of patient care.

Recs

0
Player Avatar zdocisin (< 20) Submitted: 4/22/2008 5:31:19 PM : Underperform Start Price: $40.90 HSP Score: +20.28

Will get caught up in its own hype, and get swallowed up by not feeding its infrastructure

Featured Broker Partners


Advertisement